ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 735030 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 735030; 2) Community: the network communities that were significantly associated with the response to NSC 735030; 3) Molecule: the relationships between components within communities and NSC 735030; 4) MDR: the compounds that were significantly associated with the NSC 735030.

NSC Compound Enrichment Correlation
NSC 637921 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- 0.00824865245912282 -0.31745045
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.00824865245912282 0.3727187
NSC 666787 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate 0.00824865245912282 0.3271296
NSC 681104 Phosphonic acid, [1,4,7,10-tetraazacyclododecane-1,7-diylbis(methylene)]bis- 0.00824865245912282 0.46054234
NSC 717189 Null 0.00824865245912282 0.47192855
NSC 733755 Null 0.00824865245912282 0.30734021
NSC 100880 Camptothecin 0.00824865245912294 0.037720194
NSC 129757 Null 0.00824865245912294 0.16720906
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.00824865245912294 0.25053628
NSC 380856 ACRONYCINE, 2-NITRO 0.00824865245912294 0.13932283
Total:86  Current:18    [First] [Prev] [Next] [Last]